Company Filing History:
Years Active: 1996
Title: The Innovations of Robert M. Logan
Introduction
Robert M. Logan is a notable inventor based in Greenwood, Indiana. He has made significant contributions to the field of biochemistry, particularly in the development of glycopeptide antibiotics. His work has implications for the pharmaceutical industry, especially in antibiotic development.
Latest Patents
Logan holds a patent for the "Biotransformation of glycopeptide antibiotics." This patent describes new glycopeptides prepared by the biotransformation of a vancomycin-type antibiotic using an Acinomadura citrea culture (NRRL 18382). The methods outlined in the patent involve adding a vancomycin-type glycopeptide to a growing culture of Actinomadura citrea NRRL 18382 and continuing fermentation under submerged aerobic conditions. These biotransformed intermediates are useful in various applications.
Career Highlights
Robert M. Logan is associated with Eli Lilly and Company, a leading pharmaceutical firm. His work at Eli Lilly has allowed him to focus on innovative solutions in antibiotic development. His contributions have been instrumental in advancing the understanding and application of glycopeptide antibiotics.
Collaborations
Logan has collaborated with notable colleagues, including Manuel Debono and Gary G. Marconi. These partnerships have fostered a collaborative environment that enhances research and innovation in their field.
Conclusion
Robert M. Logan's work exemplifies the intersection of innovation and practical application in the pharmaceutical industry. His contributions to glycopeptide antibiotics are significant and continue to influence the field.